How Does HIV Cause AIDS?
The DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Abstract
Many questions have been posed about acquired immunodeficiency syndrome (AIDS) pathogenesis. Is human immunodeficiency virus (HIV) both necessary and sufficient to cause AIDS? Is AIDS essentially an autoimmune disease, triggering apoptosis, or is virus infection the cause of T helper lymphocyte depletion? What is the significance of HIV tropism and the role of macrophages and dendritic cells in AIDS? Is there viral latency and why is there usually a long period between infection and AIDS? Is HIV variation a crucial aspect of its pathogenesis and, if so, do virulent strains emerge? Although this article provides few definitive answers, it aims to focus commentary on salient points. Overall, it is increasingly evident that both the tropism and burden of HIV infection correlate closely with the manifestations of disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
Self-citationGottlieb, M. S., Schroff, R., Schanker, H. M., Weisman, J. D., Fan, P. T., Wolf, R. A., & Saxon, A. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112103052401 · Cited by 2,728
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.-C., & Montagnier, L. (1984) · Nature · doi:10.1038/312767a0 · Cited by 2,436
Jonjić, S., Mutter, W., Weiland, F., Reddehase, M. J., & Koszinowski, U. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1199 · Cited by 2,105
Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P., & Fauci, A. S. (1993) · Nature · doi:10.1038/362355a0 · Cited by 1,808
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
Gartner, S., Markovits, P., Markovitz, D. M., Kaplan, M. H., Gallo, R. C., & Popovic, M. (1986) · Science · doi:10.1126/science.3014648 · Cited by 1,807
Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Tenner-Racz, K., & Haase, A. T. (1993) · Nature · doi:10.1038/362359a0 · Cited by 1,419
A TH1→TH2 switch is a critical step in the etiology of HIV infection
Clerici, M., & Shearer, G. M. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90208-3 · Cited by 1,390
High Levels of HIV-1 in Plasma During All Stages of Infection Determined By Competitive PCR
Piatak, M., Saag, M. S., Yang, L. C., Clark, S. J., Kappes, J. C., Luk, K.-C., Hahn, B. H., Shaw, G. M., & Lifson, J. D. (1993) · Science · doi:10.1126/science.8096089 · Cited by 1,237
Research works printed but not linked: 13
- ARMSTRONG, J. A., IMMUNOLOGY TODAY 6: 121 (1985).
- ASJO, B, LANCET 2: 234 (1986).
- COLLIN M THESIS U OXFORD (1992).
- GOUGEON, M. L., COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES 312: 529 (1991).
- HO, D. D., NEW ENGLAND JOURNAL OF MEDICINE 321: 1621 (1989). · DOI · Paper page
- HUMPHREY, J.H., VIRUS-LIKE PARTICLES IN AIDS-RELATED LYMPHADENOPATHY, LANCET 2: 643 (1984).
- MACETONIA, S.E., IMMUNOLOGY 75: 576 (1992).
- MIEDEMA, F, IMMUNODEFIC REV 3: 173 (1992).
- Mulder D. abstract PoC 4021 VIII International AIDS Conference (1992).
- Oka S. abstract PoC 4752 VIII International AIDS Conference (1992).
- SHEPPARD, H. W., JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY 5: 143 (1992).
- VALENTIN A THESIS KAROLINSKA I (1992).
- Weiss, R. A., The Retroviridae 2: 1 (1993).
Cited by
Items 101–200 of 684
Sjögren’s Syndrome and Viral Infections
Liu, Z., & Chu, A. (2021) · Rheumatology and Therapy · doi:10.1007/s40744-021-00334-8 · Cited by 62
Ameglio, F., Capobianchi, M. R., Castilletti, C., Fei, P. C., Fais, S., Trento, E., & DIANZANI, F. (1994) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb07018.x · Cited by 53
Moreno, R., Nababan, H. Y., Ota, E., Wariki, W. M. V., Ezoe, S., Gilmour, S., & Shibuya, K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003363.pub3 · Cited by 62
“If not treated, the natural progression of this syndrome winds up in death (Weiss 1993).”
BackgroundInfluentialHIV associated neurocognitive disorders
Zhou, L., & Saksena, N. K. (2013) · Infectious Disease Reports · doi:10.4081/idr.2013.s1.e8 · Cited by 59
Oscillatory and complex behaviour of Caputo-Fabrizio fractional order HIV-1 infection model
Ahmad, S., Ullah, A., Partohaghighi, M., Saifullah, S., Akgül, A., & Jarad, F. (2021) · AIMS Mathematics · doi:10.3934/math.2022265 · Cited by 50
Kassu, A., Tsegaye, A., Wolday, D., Petros, B., Aklilu, M., Sanders, E. J., Fontanet, A. L., van Baarle, D., Hamann, D., & de Wit, T. F. R. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02106.x · Cited by 50
Clark, G. F., Dell, A., Morris, H. R., Patankar, M. S., Oehninger, S., & Seppälä, M. (1997) · Molecular Human Reproduction · doi:10.1093/molehr/3.1.5 · Cited by 54
Arroyo, J., Boceta, M., González, M. E., Michel, M., & Carrasco, L. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4095-4102.1995 · Cited by 50
Karimipour, A., Karimipour, A., Jolfaei, N. A., Hekmatifar, M., Toghraie, D. S., Sabetvand, R., & Rostami, S. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.113989 · Cited by 49
RetractedModeling and optimal control of HIV/AIDS prevention through PrEP
Silva, C. J., & Torres, D. F. M. (2017) · Discrete and Continuous Dynamical Systems - S · doi:10.3934/dcdss.2018008 · Cited by 49
Mutation and control of the human immunodeficiency virus
Stengel, R. F. (2008) · Mathematical Biosciences · doi:10.1016/j.mbs.2008.03.002 · Cited by 49
Imidazolidinones and Imidazolidine‐2,4‐diones as Antiviral Agents
Swain, S. P., & Mohanty, S. (2019) · ChemMedChem · doi:10.1002/cmdc.201800686 · Cited by 50
Eisert, V., Kreutz, M. P., Becker, K., Königs, C., Alex, U., Rübsamen‐Waigmann, H., Andreesen, R., & von Briesen, H. (2001) · Virology · doi:10.1006/viro.2001.0940 · Cited by 51
Tang, S., van Rij, R. P., Silvera, D., & Andino, R. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7841-7850.1997 · Cited by 49
D’Cruz, O. J. (1999) · Molecular Human Reproduction · doi:10.1093/molehr/5.5.421 · Cited by 48
“AIDS now represents the third leading cause of death among all American women aged 25–44 years, and it is the leading cause of death among African–American women in this age group (Lindsay, 1996; Makulowich, 1997; Silver, 1997; Steinbrook, 1997).”
BackgroundInfluentialFu, Y.-H., Guo, J., Xie, Y., Yu, X., Su, Q.-T., Qiang, L., Kong, L., & Liu, Y. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b06417 · Cited by 47
Ankersmit, H. J., Deicher, R., Moser, B., Teufel, I., Roth, G. A., Gerlitz, S., Itescu, S., Wolner, E., Boltz-Nitulescu, G., & Kovařík, J. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01590.x · Cited by 46
Plant Derived Antivirals: A Potential Source of Drug Development
Ganju, S. S. L. (2013) · Journal of Virology & Antiviral Research · doi:10.4172/2324-8955.1000109 · Cited by 45
Tekir, S. D., & Ülgen, K. Ö. (2012) · Biotechnology Journal · doi:10.1002/biot.201200110 · Cited by 48
Anti-CD4 therapy for AIDS suggested by mathematical models
de Boer, R. J., & Boucher, C. A. (1996) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1996.0133 · Cited by 48
“1991) and macrophage reservoirs (Weiss 1993).”
BackgroundResultInfluentialAptamers for Anti-Viral Therapeutics and Diagnostics
Kim, T.-H., & Lee, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084168 · Cited by 44
Surface-modified nanocrystalline ceramics for drug delivery applications
Kossovsky, N., Gelman, A., Sponsler, E., Hnatyszyn, H. J., Rajguru, S., Torres, M., Pham, M., Crowder, J., Zemanovich, J., Chung, A., et al. (1994) · Biomaterials · doi:10.1016/0142-9612(94)90270-4 · Cited by 44
D’Cruz, O. J., & Uckun, F. M. (1999) · Biology of Reproduction · doi:10.1095/biolreprod60.6.1419 · Cited by 44
Murine AIDS, a Key to Understanding Retrovirus-Induced Immunodeficiency
LIANG, B., WANG, J. Y., & WATSON, R. R. (1996) · Viral Immunology · doi:10.1089/vim.1996.9.225 · Cited by 50
Shin, Y. H., Park, C. M., & Yoon, C. (2021) · Infection and Chemotherapy · doi:10.3947/ic.2020.0100 · Cited by 52
Puri, R. K., Leland, P., & Aggarwal, B. B. (1995) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1995.11.31 · Cited by 43
Ni, C., Chen, Y., Zeng, M., Pei, R., Du, Y., Tang, L., Wang, M., Hu, Y., Zhu, H., He, M., et al. (2015) · Cell Research · doi:10.1038/cr.2015.50 · Cited by 46
“Viral infections remain a threat to global health and cause either acute fatal diseases such as Ebola [1] and severe acute respiratory syndrome [2] or chronic diseases such as acquired immune deficiency syndrome (AIDS) [3] and hepatitis B [4] .”
BackgroundTargeted Gene Therapy for the Treatment of Heart Failure
Rapti, K., Chaanine, A. H., & Hajjar, R. J. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.02.005 · Cited by 48
Reddy, K. K., Singh, S. K., Dessalew, N., Tripathi, S. K., & Selvaraj, C. (2011) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2011.590803 · Cited by 42
Ijichi, S., & Osame, M. (1995) · Internal Medicine · doi:10.2169/internalmedicine.34.713 · Cited by 43
Méda, H., Doua, F., Laveissière, C., Miezan, T. W., Gaens, E., Brattegaard, K., Muynck, A. D., & Cock, K. M. D. (1995) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(95)90425-5 · Cited by 41
The Biology and Evolution of HIV
Hutchinson, J. F. (2001) · Annual Review of Anthropology · doi:10.1146/annurev.anthro.30.1.85 · Cited by 68
Regulation of HIV expression by viral genes and cytokines
Vicenzi, E., & Poli, G. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.3.328 · Cited by 41
Endocytic and Exocytic Regulation of CD4 Expression and Function
Marsh, M., & Pelchen–Matthews, A. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-79798-9_6 · Cited by 41
Morikita, T., Maeda, Y., Fujii, S., MATSUSHITA, S., Obaru, K., & Takatsuki, K. (1997) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1997.13.1291 · Cited by 40
Palafox, M. A., Iza, N., de la Fuente, M., & Navarro, R. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp806684v · Cited by 39
Speck‐Planche, A., Kleandrova, V. V., Luan, F., & Cordeiro, M. N. D. S. (2012) · Molecular BioSystems · doi:10.1039/c2mb25093d · Cited by 40
Esser, R., Glienke, W., Andreesen, R., Unger, R. E., Kreutz, M. P., Rübsamen‐Waigmann, H., & von Briesen, H. (1998) · Blood · doi:10.1182/blood.v91.12.4752 · Cited by 39
Potential Application of MicroRNA Profiling to the Diagnosis and Prognosis of HIV-1 Infection
Su, B., Fu, Y., Liu, Y., Wu, H., Ma, P., Zeng, W.-P., Zhang, T., Lian, S., & Wu, H. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03185 · Cited by 43
“For instance, Munshi’s team described miR-150 as a potential biomarker for HIV/AIDS disease progression and treatment monitoring.”
BackgroundInfluentialModai, S., Farberov, L., Herzig, E., Isakov, O., Hizi, A., & Shomron, N. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211111 · Cited by 38
Li, R., Liu, Q., Jin, Y., & Li, B. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.06.002 · Cited by 38
Current advances of CRISPR-Cas technology in cell therapy
Qiu, H.-Y., Ji, R.-J., & Zhang, Y. (2022) · Cell Insight · doi:10.1016/j.cellin.2022.100067 · Cited by 41
“Human immunodeficiency virus (HIV) People infected with HIV have compromised immune system and require lifelong medication to keep the viral load at low level (Powell et al., 2016; Weiss, 1993).”
BackgroundBio-inspired computational heuristics to study models of HIV infection of CD4+ T-cell
Raja, M. A. Z., Asma, K., & Aslam, M. S. (2017) · International Journal of Biomathematics · doi:10.1142/s1793524518500195 · Cited by 37
Bocci, V. A. (1994) · Mediators of Inflammation · doi:10.1155/s0962935194000438 · Cited by 42
Desai, D., Wu, G., & Zaman, M. H. (2010) · Lab on a Chip · doi:10.1039/c0lc00340a · Cited by 40
Mukherjee, B., Basu, S., Chowdhury, S. R., Paul, P., Choudhury, R., Kumar, A., Mondal, L., Hossain, C., & Maji, R. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s38013 · Cited by 36
Crotty, S. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.042 · Cited by 36
Ullah, R., Ellahi, R., Sait, S. M., & Mohyud‐Din, S. T. (2019) · Journal of Taibah University for Science · doi:10.1080/16583655.2019.1700676 · Cited by 35
Ullah, S., Jan, R., & Yüzbaşı, Ş. (2021) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2021.111429 · Cited by 35
Does HIV infection have an impact upon dental implant osseointegration? A systematic review
Ata‐Ali, J., Ata‐Ali, F., Di-Benedetto, N., Bagán, L., & Sebastián, J. V. B. (2015) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.20408 · Cited by 35
Allali, K., Danane, J., & Kuang, Y. (2017) · Applied Sciences · doi:10.3390/app7080861 · Cited by 35
“5776 [14] a The rate of production the virus by infected CD4+ T cells [2, 1250] [14] d4 Clearance rate of virus [0.”
BackgroundBuratti, E., Cleveland, S. M., Baralle, F. E., McLain, L., Dimmock, N. J., & Tisminetzky, S. G. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-11-2709 · Cited by 35
Singh, O., & Su, E. C. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1337-6 · Cited by 35
“AIDS is an advanced stage infection with the HIV [1].”
BackgroundVesanen, M., Stevens, C. E., Taylor, P. E., Rubinstein, P., & Saksela, K. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.9035-9040.1996 · Cited by 34
Dancing with Trojan horses: an interplay between the extracellular vesicles and viruses
Badierah, R., Uversky, V. N., & Redwan, E. M. M. M. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1756409 · Cited by 35
“…enveloped RNA virus that causes acquired immunodeficiency syndrome (AIDS), which is associated with the progressive failure of the immune system leading to the development of the lifethreatening opportunistic infections and cancer (Douek et al., 2009; Powell et al., 2016; Weiss, 1993).”
BackgroundMizuhara, T., Kato, T., Hirai, A., Kurihara, H., Shimada, Y., Taniguchi, M., Maeta, H., Togami, H., Shimura, K., Matsuoka, M., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.06.026 · Cited by 34
Global behavior of delay differential equations model of HIV infection withapoptosis
Guo, S., & Ma, W. (2015) · Discrete and Continuous Dynamical Systems - B · doi:10.3934/dcdsb.2016.21.103 · Cited by 33
Ullrich, R., Schmidt, W., Zippel, T., Schneider, T., Zeitz, M., & Riecken, E. (1998) · Pathobiology · doi:10.1159/000028012 · Cited by 35
Viruses and Langerhans cell histiocytosis: is there a link?
McClain, K. L., & Weiss, R. A. (1994) · Europe PMC (PubMed Central) · Cited by 33
Self-citationRivas, C. I., Vera, J. C., Guaiquil, V. H., Velásquez, F. V., Bórquez-Ojeda, O., Cárcamo, J. G., Concha, I. I., & Golde, D. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5814 · Cited by 33
Quigley, A. F., & Weiss, R. A. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.09.004 · Cited by 57
Self-citationArana, M. R., Tocchetti, G. N., Rigalli, J. P., Mottino, A. D., & Villanueva, S. S. M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.014 · Cited by 41
HIV causes AIDS: Koch's postulates fulfilled
O’Brien, S. J. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80075-6 · Cited by 32
Reddy, K. K., Singh, P. C., & Singh, S. K. (2013) · Molecular BioSystems · doi:10.1039/c3mb70418a · Cited by 34
DCAF1 controls T-cell function via p53-dependent and -independent mechanisms
Guo, Z., Kong, Q., Liu, C., Zhang, S., Zou, L., Yan, F., Whitmire, J. K., Xiong, Y., Chen, X., & Wan, Y. Y. (2016) · Nature Communications · doi:10.1038/ncomms10307 · Cited by 36
Time-Fractional Order Biological Systems with Uncertain Parameters
Chakraverty, S., Jena, R. M., & Jena, S. K. (2020) · Synthesis lectures on mathematics and statistics · doi:10.1007/978-3-031-02423-8 · Cited by 32
Immune escape and tropism of HIV
McKnight, Á., & Clapham, P. R. (1995) · Trends in Microbiology · doi:10.1016/s0966-842x(00)88975-1 · Cited by 32
Speck‐Planche, A., & Kleandrova, V. V. (2011) · Molecular Diversity · doi:10.1007/s11030-011-9337-y · Cited by 32
HIV-1 capsid and viral DNA integration
Dwivedi, R., Prakash, P., Kumbhar, B. V., Balasubramaniam, M., & Dash, C. (2023) · mBio · doi:10.1128/mbio.00212-22 · Cited by 34
Combined ligand and structure-based approaches on HIV-1 integrase strand transfer inhibitors
Reddy, K. K., & Singh, S. K. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.04.011 · Cited by 32
Analysis and Optimal Control of an Intracellular Delayed HIV Model with CTL Immune Response
Allali, K., Harroudi, S., & Torres, D. F. M. (2018) · Mathematics in Computer Science · doi:10.1007/s11786-018-0333-9 · Cited by 30
Tan, M., & Jiang, X. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11090472 · Cited by 33
“HIV infection harms the human immune system by destroying the white blood cells that fight infection, putting HIV-infected patients at risk for serious infections, eventually leading to acquired immunodeficiency syndrome (AIDS) [67,68].”
BackgroundRecent Developments of Flavonoids with Various Activities
Sun, Z.-G., Li, Z.-N., Zhang, J.-M., Hou, X.-Y., Yeh, S. M., & Ming, X. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220117111858 · Cited by 32
Shin, D., Martínez, S. S., Parsons, M., Jayaweera, D. T., Campa, A. L., & Baum, M. K. (2012) · International Journal of Bioscience Biochemistry and Bioinformatics · doi:10.7763/ijbbb.2012.v2.104 · Cited by 30
CD4 T cells remain the major source of HIV-1 during end stage disease
van der Ende, M. E., Schutten, M., Raschdorff, B., Groβschupff, G., Rácz, P., Osterhaus, A. D. M. E., & Tenner‐Racz, K. (1999) · AIDS · doi:10.1097/00002030-199906180-00002 · Cited by 30
Human immunodeficiency virus type 1 (HIV-1) and human hematopoietic progenitor cells
Re, M. C., Furlini, G., Zauli, G., & Plaça, M. L. (1994) · Archives of Virology · doi:10.1007/bf01311169 · Cited by 30
The Values of Prothrombin Time among HIV Positive Patients in FMC Owerri
Obeagu, E. I., Obeagu, G. U., & Okpara, M. O. (2015) · Cited by 29
The values of activated partial thromboplastin time (APTT) among HIV positive patients in FMC Owerri
Obeagu, E. I., Obeagu, G. U., & Okpara, M. O. (2015) · Cited by 29
Liu, Z., & Lu, P. (2014) · Advances in Difference Equations · doi:10.1186/1687-1847-2014-298 · Cited by 33
HIV-1 Tat potently stabilises Mdm2 and enhances viral replication
Raja, R., Ronsard, L., Lata, S., Trivedi, S., & Banerjea, A. C. (2017) · Biochemical Journal · doi:10.1042/bcj20160825 · Cited by 30
Roles of peptidyl-prolyl isomerase Pin1 in disease pathogenesis
Li, J., Mo, C., Guo, Y., Zhang, B., Feng, X., Si, Q., Wu, X., Zhao, Z., Gong, L., He, D., et al. (2021) · Theranostics · doi:10.7150/thno.45889 · Cited by 34
Drug Discovery and Development
Blass, B. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411508-8.00001-3 · Cited by 33
Stamatatos, L., Werner, A., & Cheng‐Mayer, C. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4973-4979.1994 · Cited by 29
Ribozymes in gene therapy of HIV-1
Macpherson, J. L. (1999) · Frontiers in bioscience · doi:10.2741/macpherson · Cited by 29
Global issues of genetic diversity
Vida, G. (1994) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8510-2_2 · Cited by 33
Prediction of cross‐clade HIV‐1 T‐cell epitopes using immunoinformatics analysis
Khairkhah, N., Namvar, A., Kardani, K., & Bolhassani, A. (2018) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25609 · Cited by 28
Lichae, B. H., Biazar, J., & Ayati, Z. (2019) · Computational and Mathematical Methods in Medicine · doi:10.1155/2019/4059549 · Cited by 28
“AIDS is one the most important and dangerous diseases in our time.”
BackgroundInfluentialKassu, A., MOHAMMAD, A., Fujimaki, Y., Moges, F., ELIAS, D., Mekonnen, F., MENGISTU, G., YAMATO, M., Wondmikun, Y., & Ota, F. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02597.x · Cited by 28
Chetty, R. (1998) · Histopathology · doi:10.1046/j.1365-2559.1998.00501.x · Cited by 28
Huang, T., Xu, Z., Chen, L., Cai, Y., & Kong, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017291 · Cited by 29
“Acquired immunodeficiency syndrome (AIDS) is caused by human immunodeficiency virus (HIV), which is a member of the retrovirus family [1].”
BackgroundThe biological context of HIV-1 host interactions reveals subtle insights into a system hijack
Dickerson, J. E., Pinney, J. W., & Robertson, D. L. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-80 · Cited by 31
On the intra-host dynamics of HIV-1 infections
Stilianakis, N. I., & Schenzle, D. (2005) · Mathematical Biosciences · doi:10.1016/j.mbs.2005.09.003 · Cited by 28
“Antigenicity has received the bulk of attention, with limited consideration of aspects like tropism and virulence sufficiently [ 25 ].”
BackgroundSensitization of the HIV-1-LTR upon Long Term Low Dose Oxidative Stress
Kurata, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.21798 · Cited by 28
Branch, D. R., Valenta, L. J. E., Yousefi, S., Sakac, D., Singla, R., Bali, M., Sahai, B. M., & Ma, X. (2002) · AIDS · doi:10.1097/00002030-200202150-00001 · Cited by 28
Poli, G., Kinter, A. L., Vicenzi, E., & Fauci, A. S. (1994) · Research in Immunology · doi:10.1016/s0923-2494(05)80036-7 · Cited by 28
Natural variation in HIV infection: Monte Carlo estimates that include CD8 effector cells
Heffernan, J. M., & Wahl, L. M. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2006.05.032 · Cited by 27
Kinetic uptake profiles of cell penetrating peptides in lymphocytes and monocytes
Rodrigues, M., de la Torre, B. G., Andreu, D., & Santos, N. C. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.05.020 · Cited by 27
Xu, Y., & Lu, C. (2005) · Science in China Series C Life Sciences · doi:10.1007/bf02879664 · Cited by 27
Schenzle, D. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131916 · Cited by 27
Kovalev, G., Duus, K., Wang, L., Lee, R., Bonyhadi, M. L., Ho, D. D., McCune, J. M., Kaneshima, H., & Su, L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7555 · Cited by 27
Metadata
- Authors
- Weiss, R. A.
- Affiliations
- Institute of Cancer Research (GB)
- Corresponding author
- Weiss, Robin A.
- ORCID
- Weiss, Robin A.
- Venue
- Science
- Published
- 1993-05-28
- Volume
- 260
- Issue
- 5112
- Pages
- 1273-1279
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2096110335
- Cited by
- 680
- References
- 130
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 15 · 2023: 16 · 2022: 36 · 2021: 26 · 2020: 28 · 2019: 21 · 2018: 24 · 2017: 19 · 2016: 28 · 2015: 40 · 2014: 42 · 2013: 33 · 2012: 37
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- HIV pathogenesis, AIDS, HIV tropism, apoptosis, macrophages, dendritic cells, viral latency, autoimmune disease, immunodeficiency
- MeSH terms
- Acquired Immunodeficiency Syndrome, Animals, Antigenic Variation, Autoimmune Diseases, Dendritic Cells, HIV, Humans, Macrophages, T-Lymphocytes, Genetic Variation, Virulence, HIV Antigens, HIV Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.